Alps Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 4.94 M
- Company Age 44 Year, 10 Months
- Satisfied Charges ₹ 2.00 Cr
About Alps Pharmaceuticals
Company Details
- Location Uttar Pradesh, Uttar Pradesh
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24232UP1980PTC004992
- Company No.
004992
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Apr 1980
- Date of AGM
-
- Date of Balance Sheet
-
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Alps Pharmaceuticals?
Board Members (3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Shailesh Chaturvedi ![]() | Director | 28-Jan-2005 | Current |
Khajanchandra Joshi ![]() | Director | 16-Apr-1980 | Current |
Jayesh Shukla ![]() | Director | 28-Jan-2005 | Current |
Financial Performance of Alps Pharmaceuticals.
Enhance accessibility to Alps Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
What is the Ownership and Shareholding Structure of Alps Pharmaceuticals?
Unlock access to Alps Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Charges (Loans)
₹0
₹2.00 Cr
Charges Breakdown by Lending Institutions
- Dena Bank : 2.00 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
23 Aug 2005 | Dena Bank | ₹2.00 Cr | Satisfied |
How Many Employees Work at Alps Pharmaceuticals?
Alps Pharmaceuticals has a workforce of 64 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Alps Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Alps Pharmaceuticals's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.